Curcumin causes promoter hypomethylation and increased expression of FANCF gene in SiHa cell line
- 2 February 2012
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 365 (1-2) , 29-35
Abstract
Curcumin and resveratrol were evaluated for their potential to cause reversal of promoter hypermethylation and associated gene expression of FANCF in SiHa cell line. Methylation specific PCR along with bisulphite sequencing revealed the demethylation of 12 CpG sites out of 15 CpG sites spanning +280 to +432 region of FANCF promoter after treatment with curcumin and fivefold up regulation of FANCF gene expression as shown by qRT-PCR. In vitro methylation assay also showed that M.SssI an analogue of DNMT1 was effectively inhibited at 50 μM concentration of curcumin. Resveratrol was not found to be effective in causing reversal of promoter hypermethylation of FANCF gene when used at 20 μM for 4 days in SiHa cell line.Keywords
This publication has 27 references indexed in Scilit:
- Targeted Methylation of Two Tumor Suppressor Genes Is Sufficient to Transform Mesenchymal Stem Cells into Cancer Stem/Initiating CellsCancer Research, 2011
- Hypomethylation effects of curcumin, demethoxycurcumin and bisdemethoxycurcumin on WIF-1 promoter in non-small cell lung cancer cell linesMolecular Medicine Reports, 2011
- Lack of Evidence for Green Tea Polyphenols as DNA Methylation Inhibitors in Murine ProstateCancer Prevention Research, 2009
- Modulation of DNA Methylation by a Sesquiterpene Lactone ParthenolideThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-scienceGynecologic Oncology, 2009
- Discovery of Two Novel, Small-Molecule Inhibitors of DNA MethylationJournal of Medicinal Chemistry, 2005
- The Fanconi Anemia Gene Product FANCF Is a Flexible Adaptor ProteinJournal of Biological Chemistry, 2004
- Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survivalOncogene, 2003
- Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumorsNature Medicine, 2003
- Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaProceedings of the National Academy of Sciences, 1998